TSMHT
BHC icon

Thurston Springer Miller Herd & Titak’s Bausch Health BHC Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,250
Closed -$8.32K – 611
2025
Q2 		$8.32K Hold
1,250
– – ﹤0.01% 1179
2025
Q1 		$8.09K Hold
1,250
– – ﹤0.01% 1172
2024
Q4 		$10.1K Hold
1,250
– – ﹤0.01% 884
2024
Q3 		$10.2K Hold
1,250
– – ﹤0.01% 1012
2024
Q2 		$8.71K Buy
+1,250
New +$9.46K ﹤0.01% 1070

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's BHC Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Bausch Health (BHC) in Q3 2025, closing a stake of 1,250 shares — an estimated $8.32K sold.

Thurston Springer Miller Herd & Titak first reported a position in BHC in Q2 2024 and held it in 5 quarters. The position peaked at $10.2K in Q3 2024. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Bausch Health position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 1,250 Bausch Health shares in Q3 2025, an estimated $8.32K.
  • Thurston Springer Miller Herd & Titak first reported a position in Bausch Health in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's Bausch Health position peaked at $10.2K in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.